BETA DRUGS LIMITED (BETA)

NSE: ₹1,471.70
Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 182.05 203.59 87.27 93.96
YOY Revenue Growth % - - - -
Other Income 4.93 5.98 2.31 2.89
Total Income 186.98 209.57 89.58 96.86
Total Expenses + 158.22 177.48 79.11 85.03
Cost of Materials Consumed 87.96 104.53 32.50 36.78
Employee Benefit Expense 17.68 19.23 16.82 18.68
Other Expenses 42.33 44.31 17.42 21.51
Operating Profit 23.83 26.11 8.16 8.94
OPM % 13.1% 12.8% 9.4% 9.5%
Profit Before Tax + 24.19 32.09 10.47 11.83
Tax Expense 24.19 32.09 1.95 2.78
Tax % 100% 100% 18.7% 23.5%
Profit After Tax 0.00 0.00 8.52 9.05
EPS (Basic) 17.81 47.38 8.40 8.93

Yearly Financial Results

Consolidated Standalone
No yearly financial data available for Consolidated.